Clik here to view.
Micrima brings in $3.4m for breast imaging tech
Micrima said today it raised $3.4 million (UK £2.6 million) in a new round of financing to support its Maria breast imaging system, with commercialization slated for the end of the year. Micrima’s...
View ArticleClik here to view.
Site selection – What to look for?
Selecting clinical sites for research purposes may be a difficult and seemingly overwhelming task for a sponsor. Familiarity with a site might help with selection, but multiple contributing factors can...
View ArticleClik here to view.
Braun lands FDA nod for Xevonta dialyzer
B. Braun Medical said today it won FDA 510(k) clearance for its xevonta dialyzer and that it is launching the next-generation filter in the U.S. Get the full story at our sister site, Medical Design...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 1, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Proton therapy demand wave drives expansion of Belgium’s IBA
(Reuters) – When Yves Jongen stood at the controls of his proton therapy machine 15 years ago to treat a cancer patient for the first time he was petrified. Now Jongen’s company IBA is hiring 400...
View ArticleClik here to view.
Novo Nordisk CEO Sorenson steps down | Personnel Moves Sept 1, 2016
Novo Nordisk CEO Sorenson steps down Novo Nordisk (NYSE:NVO) said today its current prez and chief exec Lars Sorenson will retire from his position at the end of the year, with current corp dev head...
View ArticleClik here to view.
Navigant buys Dymedex Consulting
Navigant today said it is buying data-driven market analysis consulting firm Dymedex Consulting for an undisclosed amount. Get the full story at our sister site, Medical Design & Outsourcing. The...
View ArticleClik here to view.
Bonesupport touts high infection eradication rate in prospective trial
Bonesupport today released data from the prospective trial of its Cerament G injectable antibiotic-eluting bone substitute, touting a 96% infection eradication rate in patients treated with the...
View ArticleClik here to view.
Study leads to insulin injection recommendations
(Reuters) – Many people who inject themselves with insulin to control diabetes are improperly performing this vital task, according to a large new study. Based on the results, experts have crafted...
View ArticleClik here to view.
Study: Respicardia neurostim implant shows promise in treating central sleep...
An implanted neurostimulator developed by Respicardia has been shown to significantly improve symptoms of central sleep apnea without serious side effects, according to a new study from the Ohio State...
View ArticleClik here to view.
Parexel shares slide on embezzlement news
Parexel saw shares drop 4.3% after releasing information on the embezzlement of corporate funds at one of the company’s international operations in an SEC filing. Get the full story at our sister site,...
View ArticleClik here to view.
Seeing inside: Beta cell transplants to treat diabetes
Type 1 diabetes afflicts more than 300 million people worldwide. Researchers have long sought a way to replace the insulin-producing beta cells lost in the disease, but transplanted cells are...
View ArticleClik here to view.
Nestlé’s health science unit inks staged acquisition of Phagesis
The health science business owned by Nestlé (VTX:NESN) said yesterday that it agreed to a staged acquisition of Phagenesis and its device for treating patients who can’t swallow. The deal calls for an...
View ArticleClik here to view.
ITC bows out of Align complaint against ClearCorrect, battle to play out in...
The U.S. International Trade Commission last week declined to fight for its authority to regulate data, leaving the battle between Align Technology‘s (NSDQ:ALGN) and ClearCorrect to play out in patent...
View ArticleClik here to view.
Unilife: Ex-CEO Shortall’s shenanigans exposed ‘material weaknesses’
Shares in Unilife (NSDQ:UNIS) are off 7% this week after the company said its investigation into former CEO Alan Shortall turned up “material weaknesses” in its bookkeeping procedures that will require...
View ArticleClik here to view.
Hocoma merges with DIH International
Swiss medtech company Hocoma said yesterday it merged with Hong Kong-based corporate holding group DIH International. Hocoma develops robotic and sensor-based rehabilitation solutions, and will join...
View ArticleClik here to view.
Masimo retools Nellcor royalty deal with Medtronic
Masimo (NSDQ:MASI) said today that it re-tooled the royalty agreement it won a decade ago after a $263 million patent infringement win over then-Tyco Healthcare subsidiary Nellcor, now owned by...
View ArticleClik here to view.
FDA bans certain OTC antimicrobial hand, body washes
The FDA today issued a final rule banning certain over-the-counter antibacterial hand and body wash products due to a lack of evidence showing they are safe for long-term daily use or more effective...
View ArticleClik here to view.
Nemaura Medical inks JV deal with Chinese Academy of Science affiliate
Nemaura Medical said today it inked a letter of intent to form a joint venture deal with Chinese Academy of Science subsidiary Shenzen CAS Health Corporation Limited. Through the deal, the companies...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for Sept. 2, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article
